Investor · Boston, MA

Elisabeth A. Leiderman

Open Elisabeth in the network graph →

Filings

3

SEC Form D

Connections

51

co-filers

Capital

$59.1M

across filings

Active

Sep 2025

to Sep 2025

Most-connected co-filers (51)

Lindsay Gorrill · Coeur d'Alene, ID1 shared Akash Patel · VANCOUVER, British Columbia, Canada1 shared Jay Bellows · Waterbury, VT1 shared Barry R. Mandel · Milwaukee, WI1 shared Regina A. Barzilay, Ph.D · Boston, MA1 shared Anthony A. Hyman, Ph.D · Boston, MA1 shared Srinivas H. Akkaraju, M.D., Ph.D · Boston, MA1 shared Mark A. Murcko, Ph.D · Boston, MA1 shared Lori A. Escobedo · Boston, MA1 shared Ameet A. Nathwani, M.D · Boston, MA1 shared Olivier H. Brandicourt, M.D · Boston, MA1 shared Richard A. Young, Ph.D · Boston, MA1 shared Isaac A. Klein, M.D., Ph.D · Boston, MA1 shared Pablo Villalba · Wilmington, DE1 shared Firat Yerlikaya · Wilmington, DE1 shared Adam Silver · San Francisco, CA1 shared Paul Coombs · Waterbury, VT1 shared Gregg Noble · Waterbury, VT1 shared Braxten Gorrill · Waterbury, VT1 shared American Revitalization Company, LLC · Nashville, TN1 shared Matthew D. Still · Nashville, TN1 shared Matias Gandulfo · Montara, CA1 shared Shawn B. Grosser · Bethesda, MD1 shared Christine A. Poon · Newark, NJ1 shared

Recent filings (3)

Dewpoint Therapeutics, Inc.Sep 2025 · 34 co-filers$59.1M Dewpoint Therapeutics, Inc.Sep 2025 · 34 co-filers$59.1M Autolus Therapeutics plcFeb 2024 · 34 co-filers$200.0M Autolus Therapeutics plcFeb 2024 · 34 co-filers$200.0M Decibel Therapeutics, Inc.Nov 2020 · 11 co-filers$82.2M Decibel Therapeutics, Inc.Nov 2020 · 11 co-filers$82.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Elisabeth in the interactive graph →